That's interesting, Credit Suisse saying A2 is losing stage 1 market share.....
A2 annual reports says "Sales of a2 至初® China label infant nutrition of $389.9 million, up 15.4%" & " Overall infant nutrition market in China decreased in volume1 during FY21 driven by a significant reduction in birth rates, particularly impacting early stage products, partially offset by increased product penetration"
mmm wouldn't have anything to do with potentially Credit Suisse being the bank/advisor of another Swiss coy would it?
Media Updates, page-9994
-
- There are more pages in this discussion • 4,701 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.70 |
Change
-0.010(0.18%) |
Mkt cap ! $4.113B | |||
| Open | High | Low | Value | Volume |
| $5.70 | $5.73 | $5.67 | $1.453M | 255.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 10460 | $5.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.70 | 6694 | 8 |
View Market Depth
| Last trade - 12.42pm 28/08/2024 (20 minute delay) ? |
| A2M (ASX) Chart |